Abstract CT232: Efficacy and safety of toripalimab adjuvant therapy of high-risk factors in stage IA2-IB NSCLC without EGFR and ALK mutation after complete resection treatment (TORAT): A prospective, single-arm study
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Wei Wei, Zhenfa Zhang, Changli Wang, Dongsheng Yue
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409822346